A detailed history of Mcdonald Capital Investors Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mcdonald Capital Investors Inc holds 136,453 shares of REGN stock, worth $102 Million. This represents 9.55% of its overall portfolio holdings.

Number of Shares
136,453
Previous 139,199 1.97%
Holding current value
$102 Million
Previous $146 Million 1.95%
% of portfolio
9.55%
Previous 9.77%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$1024.09 - $1201.76 $2.81 Million - $3.3 Million
-2,746 Reduced 1.97%
136,453 $143 Million
Q2 2024

Aug 01, 2024

SELL
$883.2 - $1071.19 $1.6 Million - $1.94 Million
-1,814 Reduced 1.29%
139,199 $146 Million
Q1 2024

May 03, 2024

SELL
$902.69 - $993.35 $2.27 Million - $2.5 Million
-2,516 Reduced 1.75%
141,013 $136 Million
Q4 2023

Jan 30, 2024

SELL
$775.18 - $881.7 $2.01 Million - $2.28 Million
-2,590 Reduced 1.77%
143,529 $126 Million
Q3 2023

Oct 27, 2023

SELL
$692.45 - $844.37 $2.13 Million - $2.6 Million
-3,080 Reduced 2.06%
146,119 $120 Million
Q2 2023

Jul 11, 2023

SELL
$700.03 - $830.35 $2.29 Million - $2.71 Million
-3,265 Reduced 2.14%
149,199 $107 Million
Q1 2023

Jul 11, 2023

SELL
$680.49 - $826.97 $2.8 Million - $3.41 Million
-4,122 Reduced 2.63%
152,464 $125 Million
Q4 2022

Feb 07, 2023

SELL
$705.89 - $766.39 $3.1 Million - $3.36 Million
-4,385 Reduced 2.72%
156,586 $113 Million
Q3 2022

Nov 04, 2022

SELL
$573.97 - $724.32 $1.79 Million - $2.25 Million
-3,111 Reduced 1.9%
160,971 $111 Million
Q2 2022

Aug 01, 2022

SELL
$548.35 - $738.84 $839,523 - $1.13 Million
-1,531 Reduced 0.92%
164,082 $97 Million
Q1 2022

May 02, 2022

SELL
$595.12 - $698.43 $321,364 - $377,152
-540 Reduced 0.33%
165,613 $116 Million
Q4 2021

Feb 03, 2022

SELL
$543.48 - $670.97 $910,329 - $1.12 Million
-1,675 Reduced 1.0%
166,153 $105 Million
Q3 2021

Nov 03, 2021

SELL
$574.03 - $680.96 $3.79 Million - $4.5 Million
-6,610 Reduced 3.79%
167,828 $102 Million
Q2 2021

Aug 03, 2021

SELL
$472.8 - $558.54 $1.59 Million - $1.88 Million
-3,368 Reduced 1.89%
174,438 $97.4 Million
Q1 2021

Apr 23, 2021

SELL
$446.73 - $548.2 $163,056 - $200,093
-365 Reduced 0.2%
177,806 $84.1 Million
Q4 2020

Feb 05, 2021

SELL
$478.3 - $607.98 $845,634 - $1.07 Million
-1,768 Reduced 0.98%
178,171 $86.1 Million
Q3 2020

Nov 09, 2020

SELL
$544.75 - $658.21 $740,315 - $894,507
-1,359 Reduced 0.75%
179,939 $101 Million
Q2 2020

Jul 30, 2020

SELL
$493.32 - $643.92 $5.07 Million - $6.61 Million
-10,270 Reduced 5.36%
181,298 $113 Million
Q1 2020

Apr 30, 2020

SELL
$336.18 - $494.43 $1.44 Million - $2.12 Million
-4,295 Reduced 2.19%
191,568 $93.5 Million
Q4 2019

Feb 07, 2020

SELL
$274.13 - $376.51 $3.79 Million - $5.2 Million
-13,817 Reduced 6.59%
195,863 $73.5 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $4.56 Million - $5.31 Million
16,680 Added 8.64%
209,680 $58.2 Million
Q2 2019

Aug 06, 2019

BUY
$299.6 - $414.82 $17.4 Million - $24.1 Million
58,015 Added 42.98%
193,000 $60.4 Million
Q1 2019

May 01, 2019

SELL
$372.08 - $439.57 $2.02 Million - $2.39 Million
-5,435 Reduced 3.87%
134,985 $55.4 Million
Q4 2018

Feb 01, 2019

BUY
$335.82 - $403.04 $12.1 Million - $14.5 Million
35,885 Added 34.33%
140,420 $52.4 Million
Q3 2018

Oct 31, 2018

BUY
$351.14 - $408.51 $33 Million - $38.4 Million
94,035 Added 895.57%
104,535 $42.2 Million
Q2 2018

Jul 30, 2018

BUY
$284.6 - $344.99 $2.99 Million - $3.62 Million
10,500 New
10,500 $3.62 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mcdonald Capital Investors Inc Portfolio

Follow Mcdonald Capital Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Capital Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Capital Investors Inc with notifications on news.